Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: A case report

Trastuzumab-related cardiotoxicity has been reported in patients receiving trastuzumab concurrently with other agents, especially with anthracyclines. Cardiac function damage is generally rare, precox and mild with trastuzumab alone. | Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient A case report

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN